Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-14-038524)

Filing Details

Accession Number:: 0001181431-14-038524
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-10 17:11:32
Reporting Period:: 2014-12-08

Filing Date:: 2014-12-10
Accepted Time:: 2014-12-10 17:11:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	Pharmaceutical Preparations (2834)	364742850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585697	J. Lawrence Hineline	C/O Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032	Vp Of Finance Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-08	10,965	$16.91	76,235	No	4	S	Direct
Common Stock	Disposition	2014-12-09	11,535	$16.52	64,700	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2014. The proceeds of these sales will be used primarily to cover the reporting person's tax liability arising from option exercises.